Clinical Trials in Estonia

• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting
  2024-514135-17-00 Phase III Immunoglobulin A Nephropathy Alpine Immune Sciences Inc.
• A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participant… Recruiting
  2023-505678-14-00 Phase II Ulcerative Colitis AbbVie Deutschland GmbH & Co. KG
• CHIP-AML22/Quizartinib sub-study: study of the safety and efficacy of quizartinib in children and adolescents with FLT3-ITD positive AML wit… Recruiting
  2023-505000-27-01 Phase II newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-ty… Prinses Maxima Centrum voor Kinderoncologie B.V.
• Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting
  2022-500273-14-00 Phase II/III Atherosclerotic cardiovascular disease in patients with ESKD CSL Behring LLC
• A Phase 3 program evaluating the effect of filgotinib in subjects with active axial spondyloarthritis Recruiting
  2022-501354-10-01 Phase III axial spondyloarthritis Alfasigma S.p.A.
• A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting
  2022-500257-16-00 Phase III Diabetic Foot Infections Micurx Pharmaceuticals Inc.
• A research study to evaluate the safety and effectiveness of Zilovertamab Vedotin with or without Nemtabrutinib in adults with B-cell Malign… Recruiting
  2022-501374-19-00 Phase II Aggressive and Indolent B-cell Malignancies (mantle cell lym… Merck Sharp & Dohme LLC
• A Randomized, Placebo‐Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Di… Recruiting
  2023-507518-28-00 Phase III Acute myeloid leukemia Universitaetsklinikum Ulm AöR
• Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis Recruiting
  2024-511686-11-00 Phase III Multiple Sclerosis in pediatric patients Novartis Pharma AG
• A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting
  2025-523123-22-00 Phase III Chronic Kidney Disease Eli Lilly & Co.
• A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting
  2025-521546-23-00 Phase III Secondary progressive multiple sclerosis Novartis Pharma AG
• A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting
  2023-504957-11-00 Phase III Metastatic castration resistant prostate cancer Merck Sharp & Dohme LLC
• A Phase 2b Study of IMVT-1402 Treatment in CIDP Recruiting
  2024-517614-14-00 Phase II Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Immunovant Sciences GmbH
• Study to assess the maintenance of effect of NBI-1065845 as an adjunctive treatment in participants with Major Depressive Disorder (MDD) Recruiting
  2025-520541-72-00 Phase III Major Depressive Disorder Neurocrine Biosciences Inc.
• A Randomized, Open-Label, Controlled Phase 3 Study Comparing Daratumumab, Lenalidomide and Dexamethasone Induction followed by Linvoseltamab… Recruiting
  2024-519827-16-00 Phase III Newly Diagnosed Transplant Ineligible Multiple Myeloma Patie… Emn Trial Office S.r.l. Impresa Sociale; European Myeloma Network B.V.
• Senicapoc in patients with progressive fibrotic interstitial lung disease Recruiting
  2024-511131-97-00 Phase II Progressive Fibrotic Interstitial Lung Disease Lillebaelt Hospital
• A study on the immune response and safety of an investigational chickenpox vaccine when given to healthy children 12 to 15 months of age. Recruiting
  2024-515869-33-00 Phase III Varicella GlaxoSmithKline Biologicals
• A Study of Zasocitinib in Adults with Psoriatic Arthritis Who Have Not Taken Biologic Medicines Recruiting
  2024-513111-27-00 Phase III Psoriatic Arthritis Takeda Development Center Americas Inc.
• A study on the safety of an investigational chickenpox vaccine, when given to healthy children, 12 to 15 months of age. Recruiting
  2024-515868-31-00 Phase III Varicella GlaxoSmithKline Biologicals
• A study to evaluate the benefit of adding durvalumab after chemotherapy, durvalumab and surgery in patients with early-stage, operable, non-… Recruiting
  2023-508773-82-00 Phase III Stage IIB-IIIB (N2) resectable non small cell lung cancer ETOP IBCSG Partners Foundation
• Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca… Recruiting
  2022-502352-31-00 Phase III Colorectal Cancer (CRC) Amgen Inc.
• Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting
  2024-513009-30-00 Phase II Moderate to Severe Crohn’s Disease AbbVie Deutschland GmbH & Co. KG
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting
  2023-507353-15-00 Phase III idiopathic pulmonary fibrosis (IPF) Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH; Boehr…
• A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting
  2023-503631-18-01 Phase III Nervous system diseases Sanofi-Aventis Recherche & Developpement

Showing 25–48 of 178 trials